Dispatches from Jefferies: Why Alkermes wants Avadel, Light Chain’s hope for CD47, and more

LONDON – Jefferies Healthcare Conference may have found its groove. While last year’s long queues may be gone, the buzz is still palpable as thousands arrive in London to what observers describe ...